Conferences - Results from #8520

SIU Congress 2016: Shifting Sands: Testicular Cancer: High dose chemotherapy necessary for intermediate prognosis NSGCT? - Session Highlights October 21, 2016

SIU Congress 2016: Shifting Sands: Testicular Cancer: Revival of surgery in stage I NSGCT - Session Highlights October 21, 2016

SIU Congress 2016: Debate: T2 and T3a bladder cancer: neoadjuvant chemotherapy should be standard - Session Highlights October 21, 2016

SIU Congress 2016: Using pathway analysis and metabolic signature to predict survival in MIBC - Session Highlights October 21, 2016

SIU Congress 2016: Unmet needs in upper tract TCC - Session Highlights October 21, 2016

SIU Congress 2016: Immunotherapy for advanced urothelial cancer - Session Highlights October 21, 2016

SIU Congress 2016: Urothelial cancer: Controversies in the management of urethral cancer - Session Highlights October 21, 2016

SIU Congress 2016: Chemotherapy should precede AR targeted agents for castrate-resistant metastatic disease in young patients - Session Highlights October 21, 2016

SIU Congress 2016: Kidney Cancer, SRMs treatment should be managed with surgical excision - Session Highlights October 20, 2016

SIU Congress 2016: Localized prostate cancer, Prostate biomarkers are ready for prime time in routine detection of prostate cancer - Session Highlights October 20, 2016

SIU Congress 2016: Localized prostate cancer, The utility of prostate biomarkers for routine clinical practice has not been established - Session Highlights October 20, 2016

SIU Congress 2016: Imaging, biomarkers and new therapies, Debate: MRI can replace prostate biopsy in men with elevated PSA - Session Highlights October 20, 2016

SIU Congress 2016: Controversies in prostate cancer: The new Gleason grade scoring system: implications for decision making - Session Highlights October 20, 2016

SIU Congress 2016: Kidney Cancer, SRMs should be managed with ablation rather than surgery - Session Highlights October 20, 2016

SIU Congress 2016: Kidney Cancer, Biopsy should not be routinely performed - Session Highlights October 20, 2016

SIU Congress 2016: Kidney Cancer, Biopsy should be routinely performed - Session Highlights October 20, 2016

Value Frameworks in Oncology: What are they and how will they be used? August 24, 2016

Patient Focused Pathology Reports August 24, 2016

Quality of life considerations for patients with Muscle Invasive Bladder Cancer August 24, 2016

Bladder cancer preservation: Biomarkers of Response August 24, 2016

Page 427 of 521